| For: | Eleftheriadis T, Pissas G, Antoniadi G, Liakopoulos V, Stefanidis I. Factors affecting effectiveness of vaccination against hepatitis B virus in hemodialysis patients. World J Gastroenterol 2014; 20(34): 12018-12025 [PMID: 25232238 DOI: 10.3748/wjg.v20.i34.12018] |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v20/i34/12018.htm |
| Number | Citing Articles |
| 1 |
Khalid Eltom, Abrar Albeely, Abdel Rahim M El Hussein, Isam M Elkhidir, Khalid Enan. Occult hepatitis B virus infection in Sudan: A systematic review and meta‐analysis. JGH Open 2020; 4(5) doi: 10.1002/jgh3.12411
|
| 2 |
Nader Alaridah, Rahaf A. Jereisat, Sara Abu-Mutaw, Haneen O. Abuhani, Raba’a F. Jarrar, Rayan M. Joudeh, Basmalah Al-Hawadi, Saif Alhawadi, Razan Qasim Al-oyoun, Hasan Nassr, Mohammad Al-Taher, Bassel Qiqieh, Layan Ismail, Haneen Al-Abdallat, Anas H. A. Abu-Humaidan, Ashraf Elbahrawy. Knowledge, attitude, and practices toward Hepatitis B infection among hemodialysis patients: A nationwide study in Jordan. PLOS ONE 2024; 19(10) doi: 10.1371/journal.pone.0312226
|
| 3 |
E. Elhanan, M. Boaz, I. Schwartz, D. Schwartz, G. Chernin, H. Soetendorp, A Gal Oz, A. Agbaria, T. Weinstein. A randomized, controlled clinical trial to evaluate the immunogenicity of a PreS/S hepatitis B vaccine Sci-B-Vac™, as compared to Engerix B®, among vaccine naïve and vaccine non-responder dialysis patients. Clinical and Experimental Nephrology 2018; 22(1) doi: 10.1007/s10157-017-1416-7
|
| 4 |
Theodoros Eleftheriadis, Georgios Pissas, Vassilios Liakopoulos, Ioannis Stefanidis. Anti-PD1 Immunotherapy for Metastatic Renal Cancer Boosted Humoral Immunity In a Hemodialysis Patient. Journal of Immunotherapy 2021; 44(4) doi: 10.1097/CJI.0000000000000365
|
| 5 |
Narges Eslami, Vahdat Poortahmasebi, Javid Sadeghi, Reza Ghotaslou, Bahram Niknafs, Hossein Bannazadeh Baghi, Mahin Ahangar Oskouee, Mejdi Snoussi. Occult Hepatitis B Infection among Hemodialysis Patients in Tabriz, Northwest of Iran: Prevalence and Mutations within the S Region. Canadian Journal of Infectious Diseases and Medical Microbiology 2022; 2022 doi: 10.1155/2022/3838857
|
| 6 |
Ali Asan, Huriye Demirhan, Hülya Çetin Sorkun, Sevgi Özkan, Mehtap Aydın, Davut Akın, Bengü Tatar, Binali Çatak, Alper Şener, Şükran Köse. Factors affecting responsiveness to hepatitis B immunization in dialysis patients. International Urology and Nephrology 2017; 49(10) doi: 10.1007/s11255-017-1616-9
|
| 7 |
Diana Rodríguez-Espinosa, José Jesús Broseta, José Luis Bedini, Néstor Rodríguez, Francisco Maduell. Antibody maintenance and breakthrough infections 6 months after complete COVID-19 vaccination with the mRNA-1273 and BNT162b2 vaccines in hemodialysis patients. Clinical Kidney Journal 2022; 15(4) doi: 10.1093/ckj/sfab282
|
| 8 |
Becky Mingyao Ma, Desmond Yat Hin Yap, Terence Pok Siu Yip, Ivan Fan Ngai Hung, Sydney Chi Wai Tang, Tak Mao Chan. Vaccination in patients with chronic kidney disease—Review of current recommendations and recent advances. Nephrology 2021; 26(1) doi: 10.1111/nep.13741
|
| 9 |
Ridha H Alkhalifah, Mousa J Alhaddad, Ali T Alhashem, Hussain Alwesaibi, Abdullah A AlKhalaf, Abdullah Albin Saad, Mohammed Almattar, Makarem A Alkhalaf, Habib Alramadhan, Mohammad Albaggal. Prevalence of Hepatitis B Virus, Hepatitis C Virus, and HIV Infections in Hemodialysis Patients at Kano Kidney Center. Cureus 2023; doi: 10.7759/cureus.41769
|
| 10 |
Leslie P. Wong. The Guerilla Tactics of Hepatitis B Virus in Hemodialysis: Fighting a Stubborn Foe. Kidney Medicine 2019; 1(6) doi: 10.1016/j.xkme.2019.10.003
|
| 11 |
Said A. Al-Busafi, Ahmed Alwassief. Global Perspectives on the Hepatitis B Vaccination: Challenges, Achievements, and the Road to Elimination by 2030. Vaccines 2024; 12(3) doi: 10.3390/vaccines12030288
|
| 12 |
Tara Vinyette Saco, Alexandra T. Strauss, Dennis K. Ledford. Hepatitis B vaccine nonresponders. Annals of Allergy, Asthma & Immunology 2018; 121(3) doi: 10.1016/j.anai.2018.03.017
|
| 13 |
Yongliang Feng, Xiaohong Shi, Jing Shi, Linying Gao, Guangming Liu, Yanpeng Cheng, Minghu Pan, Chunxia Li, Jun Wang, Xuxia Guo, Yawei Zhang, Xiaofeng Liang, Suping Wang. Immunogenicity, antibody persistence, and safety of the 60 μg hepatitis B vaccine in hemodialysis patients: a multicenter, randomized, double-blind, parallel-controlled trial. Expert Review of Vaccines 2017; 16(10) doi: 10.1080/14760584.2017.1367667
|
| 14 |
Farhanah Yousaf, Sherleen Gandham, Marilyn Galler, Bruce Spinowitz, Chaim Charytan. Systematic review of the efficacy and safety of intradermal versus intramuscular hepatitis B vaccination in end-stage renal disease population unresponsive to primary vaccination series. Renal Failure 2015; 37(7) doi: 10.3109/0886022X.2015.1055698
|
| 15 |
Joshua Y Kwon, Nader D Daoud, Jana G Hashash, Michael F Picco, Francis A Farraye. Efficacy of Hepatitis B Vaccination with a Novel Immunostimulatory Sequence Adjuvant (Heplisav-B) in Patients With Inflammatory Bowel Disease. Inflammatory Bowel Diseases 2023; 29(2) doi: 10.1093/ibd/izac079
|
| 16 |
Ramy H Agwa, Taher H Elwan, Hashim Abdulrahman S Alghamdi, Abdullah Ali S Alghamdi, Fatema Ibrahim A Altaweel, Abdullah A Alghamdi, Hawraa A Alhussain, Khader Mohammed A Alsawlihah, Faisal A Alzahrani. Awareness of Hepatitis B Virus (HBV) Screening Before Marriage and Pregnancy Among Adults in the Al-Baha Region, Saudi Arabia. Cureus 2024; doi: 10.7759/cureus.52057
|
| 17 |
Xiao-Xia Geng, Zhong Tian, Zhou Liu, Xue-Mei Chen, Kai-Ju Xu. Associations between hepatitis B infection and chronic kidney disease: 10-Year results from the U.S. National Inpatient Sample. Enfermedades infecciosas y microbiologia clinica (English ed.) 2021; 39(1) doi: 10.1016/j.eimce.2020.02.012
|
| 18 |
José Jesús Broseta, Diana Rodríguez-Espinosa, José Luis Bedini, Néstor Rodríguez, Francisco Maduell. Antibody maintenance 3 months after complete messenger RNA COVID-19 vaccination in haemodialysis patients. Nephrology Dialysis Transplantation 2021; 36(12) doi: 10.1093/ndt/gfab272
|
| 19 |
Tian Yao, Yandi Li, Yidan Zhang, Yangle Sun, Yana Guo, Jianmin Wang, Xiaohui Song, Wei Zhang, Baozhu Wei, Jingen Bai, Hui Wang, Weimin Yu, Huiyuan Wang, Lu Jiao, Yinqiang Diao, Liming Liu, Shuaishuai Shi, Jie Yang, Xiaojun Ren, Wenyuan Liu, Jingai Fang, Xiaofeng Liang, Suping Wang, Yongliang Feng. Immunogenicity, Safety, and Persistence Induced by Triple- and Standard-Strength 4-Dose Hepatitis B Vaccination Regimens in Patients Receiving Hemodialysis. The Journal of Infectious Diseases 2025; 231(4) doi: 10.1093/infdis/jiae494
|
| 20 |
Hossein Hatami, Parvaneh Movafagh, Ali Ramezankhani. An Investigation of the Immune Response to Hepatitis B Vaccination in Hemodialysis Patients at Dialysis Centers of Tehran (2016) . Journal of Occupational Health and Epidemiology 2019; 8(4) doi: 10.29252/johe.8.4.171
|
| 21 |
Ira M. Jacobson, Robert S. Brown, Brian J. McMahon, Robert P. Perrillo, Robert Gish. An Evidence-based Practical Guide to Vaccination for Hepatitis B Virus. Journal of Clinical Gastroenterology 2022; 56(6) doi: 10.1097/MCG.0000000000001695
|
| 22 |
Diana Rodríguez-Espinosa, Elena Cuadrado-Payán, José Jesús Broseta. Management, Body Systems, and Case Studies in COVID-19. 2024; doi: 10.1016/B978-0-443-18703-2.00051-7
|
| 23 |
Ivan Fan-Ngai Hung, Desmond Yat-Hin Yap, Terence Pok-Siu Yip, Ricky Ruiqi Zhang, Kelvin Kai-Wang To, Kwok-Hung Chan, Sydney Chi-Wai Tang, Sing-Leung Lui, Yotam Levin, Efrat Kochba, Johnson Yiu-Nam Lau, Man-Fung Yuen, Tak-Mao Chan, Kwok-Yung Yuen. A Double-blind, Randomized Phase 2 Controlled Trial of Intradermal Hepatitis B Vaccination With a Topical Toll-like Receptor 7 Agonist Imiquimod, in Patients on Dialysis. Clinical Infectious Diseases 2021; 73(2) doi: 10.1093/cid/ciaa804
|
| 24 |
Sarah E. Bota, Eric McArthur, Kyla L. Naylor, Peter G. Blake, Kevin Yau, Michelle A. Hladunewich, Adeera Levin, Matthew J. Oliver. Long-Term Morbidity and Mortality of Coronavirus Disease 2019 in Patients Receiving Maintenance Dialysis: A Multicenter Population-Based Cohort Study. Kidney360 2024; 5(8) doi: 10.34067/KID.0000000000000490
|
| 25 |
Thilo Kolb, Svenja Fischer, Lisa Müller, Nadine Lübke, Jonas Hillebrandt, Marcel Andrée, Michael Schmitz, Claudia Schmidt, Seher Küçükköylü, Lynn Koster, Margarethe Kittel, Lea Weiland, Karl W. Dreyling, Gerd Hetzel, Ortwin Adams, Heiner Schaal, Katrin Ivens, Lars C. Rump, Jörg Timm, Johannes Stegbauer. Impaired Immune Response to SARS-CoV-2 Vaccination in Dialysis Patients and in Kidney Transplant Recipients. Kidney360 2021; 2(9) doi: 10.34067/KID.0003512021
|
| 26 |
Roisin Connolly, Mark D. Denton, Hilary Humphreys, Rachel M. McLoughlin. Would hemodialysis patients benefit from a Staphylococcus aureus vaccine?. Kidney International 2019; 95(3) doi: 10.1016/j.kint.2018.10.023
|
| 27 |
José Jesús Broseta, Diana Rodríguez-Espinosa, Néstor Rodríguez, María del Mar Mosquera, María Ángeles Marcos, Natalia Egri, Mariona Pascal, Erica Soruco, José Luis Bedini, Beatriu Bayés, Francisco Maduell. Humoral and Cellular Responses to mRNA-1273 and BNT162b2 SARS-CoV-2 Vaccines Administered to Hemodialysis Patients. American Journal of Kidney Diseases 2021; 78(4) doi: 10.1053/j.ajkd.2021.06.002
|
| 28 |
Jennifer A. Whitaker, Kenneth Valles, Pritish K. Tosh, Gregory A. Poland. Vaccinations. 2019; doi: 10.1016/B978-0-323-55435-0.00009-4
|
| 29 |
Bartholomew Dzudzor, Kingsley Kwame Nsowah, Seth Agyemang, Sandro Vento, Vincent Amarh, Vincent Boima, Kenneth Tachi, Po-Yao Hsu. Overt and occult hepatitis B virus infection detected among chronic kidney disease patients on haemodialysis at a Tertiary Hospital in Ghana. PLOS ONE 2024; 19(3) doi: 10.1371/journal.pone.0290917
|
| 30 |
Xiao-Xia Geng, Zhong Tian, Zhou Liu, Xue-Mei Chen, Kai-Ju Xu. Associations between hepatitis B infection and chronic kidney disease: 10-Year results from the U.S. National Inpatient Sample. Enfermedades Infecciosas y Microbiología Clínica 2021; 39(1) doi: 10.1016/j.eimc.2020.02.029
|
| 31 |
José Jesús Broseta, Diana Rodríguez-Espinosa, Elena Cuadrado, Néstor Rodríguez, José Luis Bedini, Francisco Maduell. Humoral Response after Three Doses of mRNA-1273 or BNT162b2 SARS-CoV-2 Vaccines in Hemodialysis Patients. Vaccines 2022; 10(4) doi: 10.3390/vaccines10040522
|
| 32 |
Adane Adugna, Desalegn Abebaw, Baye Ashenef, Gashaw Azanaw Amare, Tabarak Malik, Yenesew Mihret Wondmagegn, Melkamu Tilahun, Worku Abie Liyew, Mohammed Jemal. Immunometabolic determinants of hepatitis B vaccine seroprotection among Ethiopian adults. Scientific Reports 2026; 16(1) doi: 10.1038/s41598-026-47048-x
|
| 33 |
Sawsan M. Abdel-Moniem, Mohammed A. Mohammed, Ziyad M. Essam El-Deen, Hanan M. Mostafa. Effects of interleukin-12 gene polymorphism on response to hepatitis B vaccination among hemodialysis Egyptian patients. The Egyptian Journal of Internal Medicine 2019; 31(4) doi: 10.4103/ejim.ejim_85_19
|
| 34 |
Casey Light, Karen Heslop, Hemant Kulkarni. Comparison of Factors Affecting the Immune Response to Hepatitis B Vaccination in Patients with Stage 5 Chronic Kidney Disease-haemodialysis and Predialysis. The Open Urology & Nephrology Journal 2024; 17(1) doi: 10.2174/011874303X304324240529133609
|
| 35 |
Maria Divani, Aikaterini Katsanaki, Christina Poulianiti, Evangelos Lykotsetas, Andriani Balatsouka, Panagiota Makri, Maria Tziastoudi, Ioannis Stefanidis, Theodoros Eleftheriadis. Lipid peroxidation marker malondialdehyde is an independent determinant of hepatitis B vaccine response in hemodialysis patients. Vaccine 2026; 87 doi: 10.1016/j.vaccine.2026.128776
|